Novel 660 300 mg (Trimethobenzamide Hydrochloride 300 mg)
Pill with imprint Novel 660 300 mg is Purple, Capsule-shape and has been identified as Trimethobenzamide Hydrochloride 300 mg. It is supplied by Gavis Pharmaceuticals.
Trimethobenzamide is used in the treatment of nausea/vomiting and belongs to the drug class anticholinergic antiemetics. FDA has not classified the drug for risk during pregnancy. Trimethobenzamide 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Novel 660 300 mg
Trimethobenzamide Hydrochloride
- Imprint
- Novel 660 300 mg
- Strength
- 300 mg
- Color
- Purple
- Size
- 14.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Anticholinergic antiemetics
- Pregnancy Category
- N - Not classified
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Gavis Pharmaceuticals
- National Drug Code (NDC)
- 43386-0660
- Inactive Ingredients
-
lactose monohydrate,
magnesium stearate,
corn starch,
D&C Red No. 28,
gelatin,
FD&C Blue No. 1,
FD&C Red No. 40,
titanium dioxide,
soya lecithin,
water,
shellac,
ethylene glycol monoethyl ether
Note: Inactive ingredients may vary.
More about trimethobenzamide
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (11)
- Drug images
- Pricing & coupons
- En español
- Drug class: anticholinergic antiemetics
Patient resources
- Drug Information
- Trimethobenzamide (Advanced Reading)
- Trimethobenzamide Intramuscular (Advanced Reading)
- Trimethobenzamide Capsules
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.